Concepedia

Kunzah Jamal

KJ

5

Publications

547

Citations

5

H-Index

2016

Active since

Affiliations

Institute of Cancer Research(Current)

Breast Cancer Now

AstraZeneca (United Kingdom)

University of Glasgow

Walter and Eliza Hall Institute of Medical Research

Kunzah Jamal is an author at Institute of Cancer Research specializing in cell signaling, medicine, and signal transduction.

Top concepts

Publications per year

2016–2020

5

Publications

5

MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death

Isabel Jaco, Alessandro Annibaldi, Najoua Lalaoui et al. · Molecular Cell · 2017 · 321 citations · Full text

Primidone blocks RIPK1-driven cell death and inflammation

Theresa Riebeling, Kunzah Jamal, Rebecca Wilson et al. · Cell Death and Differentiation · 2020 · 71 citations · Full text

Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487

Helen R. Heathcote, Sarah J. Mancini, Anastasiya Strembitska et al. · Biochemical Journal · 2016 · 67 citations · Full text

, , +23

Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1’s Cytotoxic Potential

Rebecca Feltham, Kunzah Jamal, Tencho Tenev et al. · Cell Reports · 2018 · 58 citations · Full text

, , +11

RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

Henry Smith, Kunzah Jamal, Jasbani H.S. Dayal et al. · EMBO Molecular Medicine · 2020 · 30 citations · Full text

Rows per page

1–5 of 5